NET staging ileum/ jejunum
T1: <1cm and confined to lamina propria or submucosa
T2: >1cm or invades into muscularis propria
T3: Invades into without penetration of serosa
T4: Invades beyond serosa into other organs or adjacent structures
N1: Regional mets to < 12 nodes
N2: Large mesenteric mass > 2cm and/or > 12nodes involved or extensive nodal deposits that encase the mesenteric vessels
M1 - distant mets
M1a: Liver mets
M1b: at least 1 extra-hepatic site
M1c: both hepatic and extrahepatic mets
Stage 1 disease - 95% 10 year survival
Stage 4 disease 42% 10 year survival
Duodenal/ ampullary NET staging
T1: <1cm and confined to mucosa or submucosa or SOD (ampullary)
T2: >1cm and invades muscularis propria (duodenal) or invades beyond sphincter into duodenal submucosa or muscularis (ampullary)
T3: Invades pancreas or peripancreatic tissue
T4: Invades serosa/ peritoneum or other organs
N1 - regional nodes
M1 - distant mets
M1a: Mets in liver only
M1b: Mets in at least 1 extrahepatic site
M1c: Hepatic and extrahepatic mets
Grading for SB NET
Grade 1:
low grade, Ki67 <3%, <2 mitoses
Grade 2:
Intermediate grade, Ki67 3-20%, 2-20 mitoses
Grade 3:
High grade, Ki67 > 20%, >20 mitoses
Factors affecting intestinal function in short gut
Phases of intestinal failure from short gut
Management
- IV fluids and electrolytes
- Acid suppression
TPN
Enteral feeding ASAP to facilitate adaptation
Management
- Oral diet (complex carbs, fibre, moderate fat restriction, minise oxalate if colon present)
- Isotonic fluids (avoid water, coffee, tea, hypertonic juice)
- Loperamide
- Acid suppression
- Consider ABx for SIBO
- Micronutrient supplements prn